Edgewise Therapeutics EWTX
NASDAQ EWTX
$41.23 +0.75 (+1.85%)
As of: Oct 2, 2026 · 1:26 PM EDT

Edgewise Therapeutics (EWTX) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Edgewise Therapeutics' Depreciation & Amortization (CF) came in at $500,000 for Q2 2026, unchanged from $500,000 a year earlier and down 6.9% from the prior quarter.

Analysis

Edgewise Therapeutics (EWTX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Edgewise Therapeutics reported Depreciation & Amortization (CF) of $2.04 million, down 3.6% year-over-year; for FY2025, it was $2.1 million, unchanged from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 60.0% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $2.1 million in FY2024 (+31.3%), $1.6 million in FY2023 (+300.0%), $400,000 in FY2022 (+33.3%) and $300,000 in FY2021 (+50.0%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $100,000 (Q3 2021) to $600,000 (Q4 2024).
  • Year-over-year, Depreciation & Amortization (CF) increased in four of the last eight quarters, with growth averaging 4.5%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2023 (growth of 400.0%), and the weakest in Q4 2025 (a decline of 16.7%).
  • Business Quant data shows EWTX's Depreciation & Amortization (CF) at $537,000 (Q1 2026), $500,000 (Q4 2025) and $500,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Edgewise Therapeutics 4.38 Bn 4.38 Bn - 500,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 500,000.00
Mar 31, 2026 537,000.00
Dec 31, 2025 500,000.00
Sep 30, 2025 500,000.00
Jun 30, 2025 500,000.00
Mar 31, 2025 513,000.00
Dec 31, 2024 600,000.00
Sep 30, 2024 500,000.00
Jun 30, 2024 500,000.00
Mar 31, 2024 500,000.00
Dec 31, 2023 500,000.00
Sep 30, 2023 400,000.00
Jun 30, 2023 400,000.00
Mar 31, 2023 200,000.00
Dec 31, 2022 100,000.00
Sep 30, 2022 100,000.00
Jun 30, 2022 100,000.00
Mar 31, 2022 100,000.00
Dec 31, 2021 100,000.00
Sep 30, 2021 100,000.00
API Access

Edgewise Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=EWTX&period=max&api_key=YOUR_API_KEY